SCHEMBL18658593

SCHEMBL18658593

Cc1c(CN2CCNCC2)cccc1NC(=O)c1cccc(C#N)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 2/20 0.56
KCNH2 Q12809 1/20 0.52
MRGPRX1 Q96LB2 6/20 0.47
HTR2A P28223 2/20 0.47
HTR2C P28335 2/20 0.47
HTR2B P41595 2/20 0.47
DRD2 P14416 3/20 0.46
DRD3 P35462 3/20 0.46
RORC P51449 5/20 0.46
DRD1 P21728 1/20 0.46
DRD4 P21917 1/20 0.46
DRD5 P21918 1/20 0.46
GRM5 P41594 1/20 0.46
ACKR3 P25106 2/20 0.46
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
OPRK1 P41145 1/20 0.44
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44
ADRA1B P35368 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18658595 0.88 KCNH2 (0.66) CHRM3KCNH2DRD2DRD3RORC
SCHEMBL19381140 0.80 DRD2 (0.51) CHRM3KCNH2DRD2DRD3RORC
SCHEMBL20614208 0.79 KCNH2 (0.67) KCNH2DRD2DRD3RORCDRD1
SCHEMBL17294412 0.79 KCNH2 (0.62) CHRM3KCNH2RORC
SCHEMBL17294414 0.79 KCNH2 (0.62) CHRM3KCNH2RORC
SCHEMBL20614218 0.79 KCNH2 (0.55) KCNH2DRD2DRD3RORCDRD1
SCHEMBL17182367 0.77 CHRM3 (0.53) CHRM3KCNH2DRD2DRD3RORC
SCHEMBL15777307 0.77 CHRM3 (0.53) CHRM3KCNH2DRD2DRD3RORC
SCHEMBL17295853 0.77 KCNH2 (0.58) CHRM3KCNH2RORC
SCHEMBL15783949 0.77 KCNH2 (0.71) CHRM3KCNH2RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3219711-A1 MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR-GAMMA) FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES Glaxo Group Limited (GB) 2017-09-20 EP disclosed
EP-2928885-B1 MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR-GAMMA) FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES GLAXO GROUP LTD (GB) 2017-03-22 EP disclosed